Kinrix Cannot Be Used for the 3rd Polio and 4th DTaP Doses in a 6-Year-Old
Kinrix is FDA-licensed specifically as the 5th dose of DTaP and 4th dose of IPV—not for earlier doses in the series. Your 6-year-old needs the 3rd IPV dose and 4th DTaP dose, so Kinrix is not the appropriate vaccine for this situation.
Why Kinrix Doesn't Apply Here
According to the FDA drug label and ACIP guidelines, Kinrix is indicated exclusively for children aged 4-6 years who need their 5th DTaP dose AND 4th IPV dose simultaneously 1. The child in question is behind schedule and requires:
- 3rd dose of IPV (not 4th)
- 4th dose of DTaP (not 5th)
This mismatch in dose numbers means Kinrix is not licensed for this scenario.
What the Guidelines Say
The 2008 ACIP guidance is explicit: Kinrix is "licensed for use as the fifth dose of the DTaP vaccine series and the fourth dose of the IPV series in children aged 4-6 years" 2. The FDA label reinforces this, stating Kinrix is indicated "as the fifth dose in the diphtheria, tetanus, and acellular pertussis (DTaP) vaccine series and the fourth dose in the inactivated poliovirus vaccine (IPV) series" 1.
Important Exception: If Inadvertently Given
However, if Kinrix is accidentally administered in this situation, the dose should be counted as valid and does not need repeating, provided minimum interval requirements have been met 2. This is a practical concession to avoid unnecessary revaccination, but it doesn't make Kinrix the correct choice prospectively.
What Should Be Given Instead
For a 6-year-old needing the 3rd IPV and 4th DTaP:
- Administer separate DTaP and IPV vaccines at this visit
- Ensure minimum intervals are met (4 weeks from previous doses for both vaccines) 3
- Then give Kinrix later when the child is due for the 5th DTaP and 4th IPV (which would actually be their 5th IPV if following this path)
Alternatively, if the child has received prior doses of Infanrix/Pediarix products specifically, complete the series with those same products when possible, though vaccination should not be delayed if the previous manufacturer is unknown 2.
Clinical Pitfall to Avoid
Don't confuse "age-appropriate" with "dose-appropriate." While the child's age (6 years) falls within Kinrix's licensed age range (4-6 years), the dose number in the series is what determines eligibility, not just chronological age 1. This is a common source of confusion in catch-up vaccination scenarios.